ARCHIVES

Group Chairmen Reject DCT’s Agenda For Clinical Trials Review, demand Right To Select Speakers

This article is from The Cancer Letter archive.

Vol. 04 No. 26 | June 30, 1978

Download PDF Visit The Full Archive

Related Articles

No Evidence Of Fraud Found In NCI Audit Of NSABP Trials

April 29, 1994

Facility Needs Panel Recommends $4.5-3 billion, Seven Year Program To Be Run By NIGMS Or DRR

March 4, 1988

ASC Survey Leads to Strategic Plan Development, Office In Washington

June 9, 1989

No Benefit For Radiation For Early Stage Disease Spread To Only One Node

March 26, 2010

In Brief: Mayo Director Kovach Moves To City Of Hope; Seattle Institutions Win Gene Therapy

May 20, 1994

NCCTG Plans To Conduct Phase II Study Of Brostallicin Plus Cisplatin For mTNBC

April 30, 2010